How to navigate the NHS rules on weight loss drugs

iStock/ ugurhan

By Emma Wilkinson

As NICE approves GLP-1s for more patients, keeping track of who is eligible for the drugs, when and for what conditions is becoming even more complicated. Here's what to know.

NICE have recommended that patients with existing cardiovascular disease who are also overweight are eligible for weight loss drug semaglutide. It adds to a complex picture for clinicians who are working to multiple different guidelines on who can and cannot access GLP-1 medications on the NHS. Emma Wilkinson looks at the advice.